Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

NCT02670915 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

834

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: Faster-acting insulin aspart
DRUG: insulin aspart
DRUG: insulin degludec

Sponsor

Novo Nordisk A/S